Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11760753 Benzoxazepin oxazolidinone compounds and methods of use

Patent 11760753 was granted and assigned to Genentech on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Emily Hanan

Steven T. Staben

Robert Andrew Heald

Richard Elliott

Marie-Gabrielle Braun

Calum MacLeod

Date of Patent

September 19, 2023

Patent Application Number

17075583

Date Filed

October 20, 2020

Patent Citations

US Patent 9107926 Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

US Patent 9271988 Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer

US Patent 9643980 Benzoxazepin oxazolidinone compounds and methods of use

US Patent 9650393 Benzoxazepin oxazolidinone compounds and methods of use

US Patent 10851091 Benzoxazepin oxazolidinone compounds and methods of use

US Patent 10112932 Benzoxazepin oxazolidinone compounds and methods of use

US Patent 8242104 Benzoxazepin P13K inhibitor compounds and methods of use

US Patent 8263633 Benzoxepin PI3K inhibitor compounds and methods of use

...

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11760753 Benzoxazepin oxazolidinone compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool